NCT04056624

Brief Summary

The central goal of this proposal is to examine validity and sensitivity of RS-assessed skin carotenoid status as a marker of F\&V intake in a racially and ethnically diverse sample of individuals. First, investigators will examine the association (RS Device Validity) between RS-assessed skin carotenoids and the primary outcomes of objectively-measured plasma carotenoids and self-reported F\&V consumption across four diverse groups: African-American/Black, Asian, White, and Hispanic/Latino (n=213). Then the investigators will conduct a randomized controlled trial to define the relative skin carotenoid responses (RS Device Sensitivity) across racial-ethnic groups, in comparison with plasma carotenoid responses. The investigators will conduct a 6-week randomized controlled trial of a carotenoid-containing juice intervention \[placebo control, low and high dose juice (N=156). Finally, the genetic basis for racial/ethnic group differences in skin carotenoid responses to diet will be investigated through hypothesis-driven genomic analysis of participants from Aims 1 and 2.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 14, 2019

Completed
1.9 years until next milestone

Study Start

First participant enrolled

June 28, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2022

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

June 15, 2023

Completed
Last Updated

June 15, 2023

Status Verified

May 1, 2023

Enrollment Period

10 months

First QC Date

August 9, 2019

Results QC Date

April 26, 2023

Last Update Submit

May 22, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • 3-week Change in Skin Carotenoid Status

    Skin carotenoid level is a number from 0 to 800 that approximates carotenoids in the skin. The Veggie Meter device uses pressure mediated reflection spectroscopy to assess skin carotenoid level in the fingertip. Skin carotenoid levels are positively correlated with fruit and vegetable intake. A higher score generally indicates more fruit and vegetable intake, which is thought to be a better outcome. The primary outcome was change in skin carotenoid levels calculated by the skin carotenoid value at 3 weeks minus the value at baseline.

    Change in skin carotenoid status from baseline to 3 weeks

  • 6-week Change in Skin Carotenoid Status

    Skin carotenoid level is a number from 0 to 800 that approximates carotenoids in the skin. The Veggie Meter device uses pressure mediated reflection spectroscopy to assess skin carotenoid level in the fingertip. Skin carotenoid levels are positively correlated with fruit and vegetable intake. A higher score generally indicates more fruit and vegetable intake, which is thought to be a better outcome. The primary outcome was change in skin carotenoid levels calculated by the value at 6 weeks minus the value at baseline.

    Change in skin carotenoid status from baseline to 6 weeks

Study Arms (3)

Low dose

EXPERIMENTAL

1 x 6 ounces of carotenoid-containing juice (6 mg carotenoids/6 oz)

Dietary Supplement: High carotenoid juice

High dose

EXPERIMENTAL

2 x 6 ounces of carotenoid-containing juice (12 mg carotenoids/12 oz)

Dietary Supplement: High carotenoid juice

Placebo

PLACEBO COMPARATOR

12 ounces of apple juice (negligible carotenoids 0.06 mg/12 oz)

Dietary Supplement: Placebo control - Apple juice

Interventions

High carotenoid juiceDIETARY_SUPPLEMENT

Juice with high carotenoids

High doseLow dose

Juice with negligible carotenoids

Placebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-identified as one of the racial/ethnic groups of focus
  • Read/speak English
  • Between 18 and 65 years of age
  • BMI 18.5-34.9 kg/m2
  • Non-pregnant
  • Non-lactating
  • Healthy (no chronic disease)
  • Not taking lipid-altering medication (medicines that lower cholesterol or triglycerides)
  • Weight stable (have not gained or lost more than 15 pounds in the last 3 months).

You may not qualify if:

  • Not of one of the four racial/ethnic groups of focus
  • Not able to read/speak English
  • Under 18 years of age or over 65 years of age, do not
  • BMI less than 18.5 or more than 34.9 kg/m2
  • Pregnant (or have been pregnant in the last 6 weeks)
  • Lactating
  • High blood sugar ( ≥126 mg/dl)
  • Chronic disease such as cardiovascular disease, diabetes, chronic kidney disease, diabetes cancer other than non-melanoma skin cancer (within the last 5 years), or other weight-related chronic diseases.
  • Taking medication that lowers cholesterol or triglycerides Diagnosed with/ treated for Crohn's disease.
  • Not weight stable (gained or lost more than 15 pounds in the last three months)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Minnesota

Minneapolis, Minnesota, 55454, United States

Location

East Carolina University

Greenville, North Carolina, 27834, United States

Location

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

Related Publications (3)

  • Jilcott Pitts SB, Wu Q, Laska MN, Moran NE. Two Spectroscopy Devices Can Approximate Fruit and Vegetable Intake in a Racially and Ethnically Diverse Sample. Curr Dev Nutr. 2025 Jun 4;9(7):107482. doi: 10.1016/j.cdnut.2025.107482. eCollection 2025 Jul.

  • Jilcott Pitts SB, Wu Q, Moran NE, Laska MN, Harnack L. Examining Potential Modifiers of Human Skin and Plasma Carotenoid Responses in a Randomized Trial of a Carotenoid-Containing Juice Intervention. J Nutr. 2023 Nov;153(11):3287-3294. doi: 10.1016/j.tjnut.2023.09.014. Epub 2023 Sep 23.

  • Jilcott Pitts S, Moran NE, Laska MN, Wu Q, Harnack L, Moe S, Carr-Manthe P, Gates E, Chang J, Zaidi Y, Gelineau A, Berg L, Craft NE. Reflection Spectroscopy-Assessed Skin Carotenoids Are Sensitive to Change in Carotenoid Intake in a 6-Week Randomized Controlled Feeding Trial in a Racially/Ethnically Diverse Sample. J Nutr. 2023 Apr;153(4):1133-1142. doi: 10.1016/j.tjnut.2023.02.017. Epub 2023 Feb 18.

MeSH Terms

Conditions

Feeding Behavior

Condition Hierarchy (Ancestors)

Behavior, AnimalBehavior

Results Point of Contact

Title
Stephanie Jilcott Pitts
Organization
East Carolina University, Department of Public Health

Study Officials

  • Stephanie B Jilcott Pitts, PhD

    East Carolina University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: First, investigators will examine the association (RS Device Validity) between RS-assessed skin carotenoids and the primary outcomes of objectively-measured plasma carotenoids and self-reported F\&V consumption across four diverse groups: African-American/Black, Asian, White, and Hispanic/Latino. Then investigators will conduct a randomized controlled trial to define the relative skin carotenoid responses (RS Device Sensitivity) across racial-ethnic groups, in comparison with plasma carotenoid responses. Investigators will conduct a 6-week randomized controlled trial of a carotenoid-containing juice intervention \[placebo control, low and high dose juice across 4 genetically-stratified racial-ethnic groups (n = 156).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 9, 2019

First Posted

August 14, 2019

Study Start

June 28, 2021

Primary Completion

April 14, 2022

Study Completion

April 14, 2022

Last Updated

June 15, 2023

Results First Posted

June 15, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

De-identified data will be shared with other researchers.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be available to share with other investigators 12 months after study completion.
Access Criteria
Researchers must submit a plan for analysis, obtain Institutional Review Board approval and be approved by study investigators before data are released.

Locations